Neither as harmful as feared by critics nor as empowering as promised by providers: Risk information offered direct to consumer by personal genomics companies

Journal of Community Genetics

Volumn 5, Issue 1, 2014, Pages 59-68

  Nordgren, Anders ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Direct to consumer; Ethics; Genetic testing; Policy; Risk

Indexed keywords

DNA;

ARTICLE; AUTOREGULATION; CLINICAL EFFECTIVENESS; CLINICAL SUPERVISION; COMPUTER PROGRAM; CONSUMER ADVOCACY; DATA BASE; EMPIRICAL RESEARCH; EMPOWERMENT; GENETIC COUNSELING; GENETIC RISK; GENETIC SCREENING; GENETIC SERVICE; GENOMICS; GENOTYPE; HEALTH CARE POLICY; HUMAN; INFORMATION DISSEMINATION; INFORMATION PROCESSING; INFORMED CONSENT; INTERNET; MANAGEMENT; MEDICAL ETHICS; MENTAL STRESS; PHENOTYPE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SOCIAL CONTROL; WEBSITE;

EID: 84899093188     PISSN: 1868310X     EISSN: 18686001     Source Type: Journal    
DOI: 10.1007/s12687-012-0094-0     Document Type: Article

References (60)

1. 23andMe (2012a) Core values. https://www.23andme.com/about/values. Accessed 27 January 2012
2. 23andMe (2012b) 23andMe Enlists Informed Medical Decisions to Make Independent Genetic Counseling Services Available to Customers. https://www.23andme.com/about/press/20100603/. Accessed 27 January 2012
3. 23andMe (2012c) Terms of service. https://www.23andme.com/about/tos/. Accessed 27 January 2012
4. Baars MJ, Henneman L, ten Kate LP (2005) Deficiency of knowledge of genetics and genetic tests among general practitioners, gynaecologists, and paediatricians: a global problem. Genet Med 7:605-610 (Pubitemid 41753011)
5. Beaudet AL (2010) Which way for genetic-test regulation? Leave test interpretation to specialists. Nature 466:816-817
6. Bloss CS, Schork NJ, Topol EJ (2011a) Effect of direct-to-consumer genomewide profiling to assess disease risk. N Eng J Med 364:524-534
7. Bloss CS, Darst BF, Topol EJ, Schork NJ (2011b) Direct-to-consumer personalized genomic testing. Hum Mol Gen 20(Rev Issue 2):R132-R141
8. Borry P, van Hellemondt RE, Sprumont D, Fittipaldi Duarte Jales C, Rial-Sebbag E, Spranger TM, Curren L, Kaye J, Nys H, Howard H (advance publication online 25 January 2012) Legislation on direct-to-consumer genetic testing in seven European countries. Eur J Hum Gen. doi:10.1038/ejhg.2011.278
9. Caulfield T (2011) Direct-to-consumer testing: if consumers are not anxious, why are policymakers? Hum Gen 130:23-25
10. Council of Europe (1997) Convention for the protection of Human Rights and the dignity of the human being with regard to the application of biology and medicine: Convention on Human Rights and Biomedicine, CETS No. 164. http://conventions.coe.int. Accessed 27 January 2011
11. Council of Europe (2008) Additional Protocol to the Convention of Human Rights and Medicine, concerning Genetic Testing for Health Purposes, CETS No. 203. http://conventions.coe.int. Accessed 27 January 2012
12. deCODEme (2012a) Homepage. http://www.decodeme.com. Accessed 27 January 2012
13. deCODEme (2012b) About risk. http://www.decodeme.com/health-watch- information/about-risk. Accessed 27 January 2012
14. deCODEme (2012c) Try our demo. http://www.decodeme.com/trydemo. Accessed 27 January 2012
15. deCODEme (2012d) About deCODEme. http://www.decodeme.com/about-decodeme. Accessed 27 January 2012
16. deCODEme (2012e) Service agreement. http://www.decodeme.com/service- agreement. Accessed 27 January 2012
17. deCODEme (2012f) Frequently asked questions. http://www.decodeme.com/ faq#scan1. Accessed 27 January 2012
18. Feero WG, Guttmacher AE, Collins FS (2008) The genome gets personal-almost. JAMA 299:1351-1352
19. Genetics and Public Policy Center (2010) DTC Genetic Testing Companies. http://www.dnapolicy.org/resources/DTCTableAug2011Alphabydisease.pdf. Accessed 27 January 2012
20. Gigerenzer G, Mata J, Frank R (2009) Public knowledge of benefits of breast and prostate cancer screening in Europe. J Natl Cancer Inst 101:1216-1220
21. Giovanni MA, Fickie MR, Lehmann LS, Green RC, Meckley LM, Veenstra D, Murray MF (2010) Health-care referrals from direct-to-consumer genetic testing. Genet Test Mol Biomarkers 14:817-819
22. Gollust SE, Gordon ES, Zayac C, Griffin G, Christman MF, Pyeritz RE, Wawak L, Bernhardt BA (2012) Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants. Public Health Genomics 15:22-30
23. Goodson ML, Vernon BG (2004) A study of public opinion on the use of tissue samples from living subjects for clinical research. J Clin Pathol 57:135-138 (Pubitemid 38177748)
24. Grimaldi KA, Look MP, Scioli GA, Clavero JC, Marinos S, Tagaris T (2011) Personal genetics: regulatory framework in Europe from a service provider 's perspective. Eur J Hum Gen 19:382-388
25. Gruber J (2011) Comments. FDA Public Meeting "Direct-to-consumer Genetic Testing ". Council for Responsible Genetics. http://www. councilforresponsiblegenetics.org/pageDocuments/VSGVBP8S0T.pdf. Accessed 27 January 2012
26. Gurwitz D, Bregman-Eschet Y (2009) Personal genomics services: whose genomes? Eur J Hum Gen 17:883-889
27. Heshka JT, Palleschi C, Howley H, Wilson B, Wells PS (2008) A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genet Med 10:19-32
28. Hogarth S, Javitt G, Melzer D (2008) The current landscape for direct-to-consumer genetic testing; legal, ethical, and policy issues. Annu Rev Genom Hum Genet 8:161-182
29. Howard H, Borry P (2012) Is there a doctor in the house? The presence of physicians in the direct-to-consumer genetic testing context. J Community Genet 3:105-112
30. Howard HC, Knoppers BM, Borry P (2010) Blurring lines. The research activities of direct-to-consumer genetic testing companies raise questions about consumers as research subjects. EMBO Rep 11:579-582
31. Hudson K, Javitt G, Burke W, Byers P, with the ASHG (American Society of Human Genetics) Social Issues Committee (2007) ASHG statement on direct-to-consumer genetic testing in the United States. Am J Hum Gen 81:635-637
32. Human Genetics Commission (2007) More genes direct: a report on developments in the availability, marketing and regulation of genetic tests supplied directly to the public. http://www.hgc.gov.uk/UploadDocs/DocPub/ Document/More%20Genes%20Direct.pdf. Accessed 27 January 2012
33. Imai K, Kricka LJ, Fortina P (2011) Concordance study of 3 direct-to-consumer genetic-testing services. Clin Chem 57:518-521
34. Javitt G (2010) Which way for genetic-test regulation? Assign regulation appropriate to the level of risk. Nature 466:817- 818
35. Kaye J (2008) The regulation of direct-to-consumer genetic tests. Hum Mol Gen 17(R2):R180-R183
36. Lachance CR, Erby LA, Ford BM, Allen VC Jr, Kaphingst KA (2010) Informational content, literacy demands, and usability of websites offering health-related genetic tests directly to consumers. Genet Med 12:304-312
37. Lerner-Ellis JP, Ellis JD, Green R (2010) Direct-to-consumer genetic testing: what's the prognosis? Genewatch 23(4):6-7 http://www. councilforresponsiblegenetics.org/GeneWatch/GeneWatchPage.aspx?pageId0277. Accessed 27 January 2012
38. Lewis NP, Treise D, Hsu SI, Allen WL, Kang H (2011) DTC genetic testing companies fail transparency prescriptions. New Gen Soc 30:291-307
39. Lippi G, Favarolo EJ, Plebani M (2011) Direct-to-consumer testing: more risks than opportunities. Int J Clin Pract 65:1221-1229
40. Marteau TM, French DP, Griffin SJ, Prevost AT, Sutton S, Watkinson C, Attwood S, Hollands GJ (2010) Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours. Cochrane Database Syst Rev 10:CD007275. doi:10.1002/14651858.CD007275.pub2
41. Mayo Clinic (2012) Cancer risk: what the numbers mean. http://www.mayoclinic.com/health/cancer/CA00053. Accessed 27 January 2012
42. McGowan ML, Fishman JR, Lambrix MA (2010) Personal genomics and individual identities: motivations and moral imperatives of early users. New Gen Soc 29(3):261-290
43. McGuire AL, Burke W (2008) An unwelcome side effect of direct-to-consumer personal genome testing: raiding the medical commons. JAMA 300:2669-2671
44. McGuire AL, Burke W (2011) Health system implications of direct-to-consumer personal genome testing. Public Health Genomics 14:53-58
45. McGuire AL, Diaz CM, Wang T, Hilsenbeck SG (2009) Social networkers' attitudes toward direct-to-consumer personal genome testing. Am J Bioeth 9(6-7):3-10
46. Navigenics (2012a) Homepage. http://www.navigenics.com/. Accessed 27 January 2012
47. Navigenics (2012b) Applying Preventive Genomic Medicine in Clinical Practice. http://www.navigenics.com/static/pdf/physician/physician-whitepaper. pdf. Accessed 27 January 2012
48. Navigenics (2012c) Demo. http://www.navigenics.com/demo/tutorial. Accessed 27 January 2012
49. Navigenics (2012d) Genetic counseling. http://www.navigenics.com/visitor/ what-we-offer/genetic-counseling/. Accessed 27 January 2012
50. Nippert I, Harris HJ, Julian-Reynier C, Kristoffersson U, ten Kate LP, Anionwu E, Benjamin C, Challen K, Schmidtke J, Nippert RP, Rodney Harris R (2011) Confidence of primary care physicians in their ability to carry out basic medical genetic tasks - a European survey in five countries - part 1. J Comm Gen 2:1-11
51. Nordgren A (2008) Genetics and Identity. Community Genet 11:252-266
52. Nordgren A (2010) The rhetoric appeal to identity on websites of companies offering non-health-related DNA testing. Ident Inform Soc 3:473-487
53. Nordgren A (2012) Consumer genomics companies and their appeal to empowerment. In: Derkx P, Kunneman H (eds) Genomics and democracy: towards a 'Lingua Democratica' for the public debate on genomics. Rodopi, Amsterdam (in press)
54. Nordgren A, Juengst ET (2009) Can genomics tell me who I am? Essentialistic rhetoric in direct-to-consumer DNA testing. New Gen Soc 28:157-172
55. Pathway Genomics (2012) Homepage. https://www.pathway.com/. Accessed 27 January 2012
56. Ransohoff DF, Khoury MJ (2010) Personal genomics: information can be harmful. Eur J Clin Invest 40:64-68
57. Su Y, Howard HC, Borry P (2011) Users' motivations to purchase direct-to-consumer genome-wide testing: an exploratory study of personal stories. J Comm Genet 2(3):135-146
58. United States Government Accountability Office (GAO) (2010) Direct-to-consumer Genetic Tests: Misleading Test Results Are Further Complicated by Deceptive Marketing and Other Questionable Practices. http://www.gao.gov/new.items/d10847t.pdf. Accessed 27 January 2012
59. Wegwart O, Gigerenzer G (2011) Statistical illiteracy in doctors. In: Gigerenzer G, Muir G (eds) Better doctors, better patients, better decisions: envisioning health care 2020. strungmann forum reports, vol 6, J Lupp. MIT Press, Cambridge, pp 137-151
60. Wright CF, Gregory-Jones S (2010) Size of the direct-to-consumer genomic testing market. Genet Med 12:594